Skip to main content
Press release August 27, 2026

Pulmonx to Participate in Upcoming Investor Conferences

Pulmonx Corp (LUNG)

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare
View original release